These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 36716523)

  • 1. Tumor Microenvironment Responsive Hollow Nanoplatform for Triple Amplification of Oxidative Stress to Enhance Cuproptosis-Based Synergistic Cancer Therapy.
    Xu W; Wang Y; Hou G; Wang J; Wang T; Qian J; Suo A
    Adv Healthc Mater; 2023 May; 12(13):e2202949. PubMed ID: 36716523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
    Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
    Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy of "adding fuel to the flames" enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy.
    Huang L; Zhu J; Wu G; Xiong W; Feng J; Yan C; Yang J; Li Z; Fan Q; Ren B; Li Y; Chen C; Yu X; Shen Z
    Biomaterials; 2024 Dec; 311():122701. PubMed ID: 38981152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hollow Calcium/Copper Bimetallic Amplifier for Cuproptosis/Paraptosis/Apoptosis Cancer Therapy via Cascade Reinforcement of Endoplasmic Reticulum Stress and Mitochondrial Dysfunction.
    Xu W; Suo A; Aldai AJM; Wang Y; Fan J; Xia Y; Xu J; Chen Z; Zhao H; Zhang M; Qian J
    ACS Nano; 2024 Oct; 18(43):30053-30068. PubMed ID: 39412236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial-Targeted Copper Delivery for Cuproptosis-Based Synergistic Cancer Therapy.
    Deng J; Zhuang H; Shao S; Zeng X; Xue P; Bai T; Wang X; Shangguan S; Chen Y; Yan S; Huang W
    Adv Healthc Mater; 2024 Jul; 13(18):e2304522. PubMed ID: 38530073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.
    Xu Y; Liu SY; Zeng L; Ma H; Zhang Y; Yang H; Liu Y; Fang S; Zhao J; Xu Y; Ashby CR; He Y; Dai Z; Pan Y
    Adv Mater; 2022 Oct; 34(43):e2204733. PubMed ID: 36054475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9 gene editing strengthens cuproptosis/chemodynamic/ferroptosis synergistic cancer therapy.
    Wu X; Bai Z; Wang H; Wang H; Hou D; Xu Y; Wo G; Cheng H; Sun D; Tao W
    Acta Pharm Sin B; 2024 Sep; 14(9):4059-4072. PubMed ID: 39309486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy.
    Zhou J; Yu Q; Song J; Li S; Li XL; Kang BK; Chen HY; Xu JJ
    Angew Chem Int Ed Engl; 2023 Mar; 62(12):e202213922. PubMed ID: 36585379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive Layered Double Hydroxides for Synergistic Sonodynamic/Cuproptosis Anticancer Therapy with Elicitation of the Immune Response.
    Tang W; Wu J; Wang L; Wei K; Pei Z; Gong F; Chen L; Han Z; Yang Y; Dai Y; Cui X; Cheng L
    ACS Nano; 2024 Apr; 18(15):10495-10508. PubMed ID: 38556991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox Homeostasis Disruptors Based on Metal-Phenolic Network Nanoparticles for Chemo/Chemodynamic Synergistic Tumor Therapy through Activating Apoptosis and Cuproptosis.
    Zhao F; Yu H; Liang L; Wang C; Shi D; Zhang X; Ying Y; Cai W; Li W; Li J; Zheng J; Qiao L; Che S; Yu J
    Adv Healthc Mater; 2023 Nov; 12(29):e2301346. PubMed ID: 37369362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy.
    Lu X; Chen X; Lin C; Yi Y; Zhao S; Zhu B; Deng W; Wang X; Xie Z; Rao S; Ni Z; You T; Li L; Huang Y; Xue X; Yu Y; Sun W; Shen X
    Adv Sci (Weinh); 2024 May; 11(18):e2309984. PubMed ID: 38430531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNAzyme-Mediated Cascade Nanoreactor for Cuproptosis-Promoted Pancreatic Cancer Synergistic Therapy.
    Yu Q; Zhou J; Liu Y; Li XQ; Li S; Zhou H; Kang B; Chen HY; Xu JJ
    Adv Healthc Mater; 2023 Nov; 12(28):e2301429. PubMed ID: 37548109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild-Photothermal Effect Induced High Efficiency Ferroptosis-Boosted-Cuproptosis Based on Cu
    Chen W; Xie W; Gao Z; Lin C; Tan M; Zhang Y; Hou Z
    Adv Sci (Weinh); 2023 Nov; 10(33):e2303694. PubMed ID: 37822154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier-Free Self-Assembly Nano-Sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in Glioblastoma Therapy.
    Zhu Y; Niu X; Ding C; Lin Y; Fang W; Yan L; Cheng J; Zou J; Tian Y; Huang W; Huang W; Pan Y; Wu T; Chen X; Kang D
    Adv Sci (Weinh); 2024 Jun; 11(23):e2402516. PubMed ID: 38582500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Serum Albumin Mediated Controllable Synthesis of Defect-Rich Copper Hydroxide Nanowire for Cuproptosis-Based Anti-Tumor Therapy.
    Man R; Xia M; Li H; Tian F; Zhang J; Yu Z; Tang B
    Adv Healthc Mater; 2024 Sep; 13(23):e2401078. PubMed ID: 38708719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-situ fabrication of novel Au nanoclusters-Cu
    Yang Z; Zhao Z; Cheng H; Shen Y; Xie A; Zhu M
    J Colloid Interface Sci; 2023 Jul; 641():215-228. PubMed ID: 36933468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AuPt-Loaded Cu-Doped Polydopamine Nanocomposites with Multienzyme-Mimic Activities for Dual-Modal Imaging-Guided and Cuproptosis-Enhanced Photothermal/Nanocatalytic Therapy.
    Wang YY; Zhang XY; Li SL; Jiang FL; Jiang P; Liu Y
    Anal Chem; 2023 Sep; 95(37):14025-14035. PubMed ID: 37694580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy.
    Li K; Wu L; Wang H; Fu Z; Gao J; Liu X; Fan Y; Qin X; Ni D; Wang J; Xie D
    J Nanobiotechnology; 2024 Sep; 22(1):546. PubMed ID: 39237931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulus-Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer Immunotherapy.
    Hu F; Huang J; Bing T; Mou W; Li D; Zhang H; Chen Y; Jin Q; Yu Y; Yang Z
    Adv Sci (Weinh); 2024 Apr; 11(13):e2309388. PubMed ID: 38269649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy.
    Liang W; Han C; Zhang D; Liu C; Zhu M; Xu F; Fang C; Zhang S; Liu C; Li Y
    Acta Biomater; 2024 Feb; 175():341-352. PubMed ID: 38122883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.